MYF5 is a transcriptional activator that promotes skeletal muscle differentiation by inducing transcription of muscle-specific target genes 1. As a member of the myogenic regulatory factor family, MYF5 co-occupies muscle-specific gene promoter regions alongside MYOD1 and MYOG during myogenesis, and induces fibroblast-to-myoblast differentiation 2. MYF5 expression increases significantly during myogenic differentiation in both mouse and human muscle cells 1, and is regulated by upstream metabolic pathways such as pyruvate metabolism 1. The gene plays a critical role in satellite cell biology, where it regulates quiescence, activation, and renewal of these muscle stem cells 2. Plant-derived bioactive compounds enhance MYF5 expression to counteract sarcopenia, an age-related muscle disorder characterized by loss of skeletal muscle mass and function 3. MYF5 is also implicated in stromal cell biology within tumor microenvironments, where MYF5+ muscle satellite cells associate with immunosuppressive niches 4. Additionally, MYF5-derived cellular lineages distinguish classical brown adipocytes from beige adipocytes in thermogenic fat tissue 5. Mutations in MYF5 are associated with ophthalmoplegia externus with rib and vertebral anomalies, suggesting roles beyond skeletal muscle development.